Oct 6–7, 2026 · Boston, MA
AMPERA Contributes to Commercialization Discussion at Reuters Events: Fusion Energy 2026
AMPERA joined hundreds of fusion developers, investors, policymakers, utilities, industrial energy users and researchers at Reuters Events: Fusion Energy 2026 in Boston to help advance the industry conversation around commercializing fusion technology.
Representing AMPERA, Dr. Zain Karriem participated in the panel, “From Breakthrough to Build Out: Turning Lab Innovation into Deployable Fusion Plants.” He contributed perspectives on the engineering, validation and manufacturing work needed to translate scientific progress into reliable, scalable power plants for industrial use.
The discussion explored how disciplined component testing and qualification programs can demonstrate technology readiness and commercial viability, as well as how integrated plant design can balance performance, maintainability and manufacturability.
At the AMPERA booth, attendees explored the company’s PowerNOW. NuclearNEXT™. strategy and its approach to meeting growing energy demand. Conversations highlighted how AMPERA’s Integrated Energy Architecture™ connects waste-heat recovery and conventionally fueled power generation with a pathway toward future advanced nuclear energy.
Participants walked away with a practical takeaway: commercializing advanced energy requires more than a scientific breakthrough. It also demands disciplined engineering, component testing, qualification programs, integrated plant design and scalable manufacturing. AMPERA’s participation helped focus the discussion on the capabilities required to move promising technologies toward real-world deployment.
As part of his visit to the Boston area, Dr. Karriem was also invited to tour Commonwealth Fusion Systems’ SPARC facility in Devens, Massachusetts, where he had the opportunity to see firsthand the technologies being developed for the SPARC fusion machine. The visit provided additional insight into the engineering and technology development efforts underway to advance fusion toward commercial deployment.